C-286, An Act to amend the Controlled Drugs and Substances Act and the Food and Drugs Act, would amend both Acts. It would change how psilocin and psilocybin are treated under certain drug regulations and automatically grant priority-review status to qualifying requests for certain new drug submissions. Its stated goal is to improve access to medical treatment involving these substances without bypassing existing drug-approval processes. The supplied material does not say whether the bill has passed or when the proposed changes would start.
No cost information is in the available material.
Summary matches the latest captured text
Summary version: First Reading · 2026-06-16
Last source check:
Read the latest official textBills on related subjects, starting with Canada.
If enacted, provinces would have to insure certain mental health and addiction services. It expands coverage, but rules and which services qualify remain unclear.
Status
First reading
Lawmakers would amend the Food and Drugs Act to cover natural health products, but published text shows no operative provisions or cost details.
Status
Consideration in committee
The bill would create a list of non-marketed therapies patients could request. It does not guarantee access and depends on minister decisions.
Status
Second reading
Canada Post would be required to offer alcohol delivery across provinces. Carriers could be designated to help, with rules set in regulation.
Status
First reading